Clinical trials: Covid-19 Patients
Health Behavior, Health Care Utilization
COVID-19: Healthy Oregon (Oregon Saludable): Together We Can (Juntos Podemos) Phase II
The global SARS-CoV-2 pandemic that causes the severe respiratory illness COVID-19 is the worst health crisis that the United States has faced in a century.
- Trial name
- OSJP (NCT05082935)
- Testing
- Phase II Promotores de Salud, Phase I Promotores de Salud Outreach
- Where
- United States
- Volunteers
- 1,463 people
- Sponsor
- University of Oregon
Rheumatoid Arthritis (RA), Systemic Lupus Erythematosus (SLE)
COVID-19 Booster Vaccine in Autoimmune Disease Non-Responders
This is a randomized, multi-site, adaptive, open-label clinical trial comparing the immune response to different additional doses of COVID-19 vaccine in participants with autoimmune disease requiring IS medications.
- Conditions
- Rheumatoid Arthritis (RA), Systemic Lupus Erythematosus (SLE), Pemphigus Vulgaris, Multiple Sclerosis (MS)
- Trial name
- NCT05000216
- Testing
- Moderna mRNA-1273, BNT162b2, Ad26.COV2.S
- Where
- 29 sites in United States
- Volunteers
- 258 people
- Sponsor
- National Institute of Allergy and Infectious Diseases (NIAID)
Helminths Infection, Protozoan Infections
Parasitism & COVID19 Vaccines: New Challenge.
Parasitic infection is a serious public health problem throughout the world particularly in developing countries including Egypt.
- Trial name
- NCT05185778
- Testing
- stool examination, blood sample collected
- Volunteers
- 128 people
- Sponsor
- Assiut University
Covid19, Lung Infection
COVID-19 and Lung Ultrasound Utility
Ultrasounds are usually done by a specially trained health professional in the hospital or emergency department (ED) setting. Using a novel single-probe device, the ultrasound can be plugged into an iOS / Android device.
- Trial name
- NCT04591158
- Testing
- Butterfly iQ
- Where
- Canada
- Volunteers
- 6 people
- Sponsor
- Bridge to Health Medical and Dental USA
ARDS Secondary to COVID-19 Pneumonia
CACOLAC : Citrulline Administration in the Hospital Patient in Intensive Care for COVID-19 Acute Respiratory Distress Syndrome
Respiratory involvement of SARS-CoV2 leads to acute respiratory distress syndrome (ARDS) and significant immunosuppression (lymphopenia) exposing patients to long ventilation duration and late mortality linked to the acquisition…
- Trial name
- CACOLAC (NCT04404426)
- Testing
- L-citrulline
- Where
- France
- Volunteers
- 33 people
- Sponsor
- Rennes University Hospital
Urinary Stone, Urinary Calculi
The Effect of the COVID-19 on Patient Preferences and Decision Making for Obstructive Urinary Stone Interventions
In this study, the investigators aim to evaluate the intervention preferences of patients with obstructive urinary stones who are suitable for operation during the COVID-19 pandemic.
- Conditions
- Urinary Stone, Urinary Calculi, Covid19
- Trial name
- NCT04924790
- Testing
- COVID-19 Pandemic
- Where
- Turkey (Türkiye)
- Volunteers
- 158 people
- Sponsor
- Ankara Training and Research Hospital
Thrombosis, Covid-19
Thrombosis and Covid-19
The coronavirus disease of 2019 (COVID-19) is a viral illness caused by the severe acute respiratory syndrome coronavirus 2 (SARS-CoV2), now deemed a pandemic by the World Health Organization.
- Conditions
- Thrombosis, Covid-19, SARS-CoV 2
- Trial name
- COVBIO (NCT04366778)
- Testing
- TEM-tPA
- Where
- France
- Volunteers
- 341 people
- Sponsor
- Hospices Civils de Lyon
Multiple Sclerosis, Covid19
Estimating Prevalence of COVID-19 Infection and SARS-CoV-2 Antibodies in MS Patients
This non-interventional, biospecimen collection study is designed to help us better understand whether MS patients have impaired immune defenses to COVID-19 infection.
- Trial name
- NCT04682548
- Where
- United States
- Volunteers
- 920 people
- Sponsor
- NYU Langone Health
Cancer, COPD
SELF-BREATHE RCT for Chronic Breathlessness
A feasibility RCT comprising two groups: 1. Intervention (SELF-BREATHE in addition to standard NHS care) 2. Control group (standard / currently available NHS care)
- Conditions
- Cancer, COPD, Asthma, Bronchiectasis Adult
- Trial name
- NCT04574050
- Testing
- SELF-BREATHE
- Where
- United Kingdom
- Volunteers
- 52 people
- Sponsor
- King's College Hospital NHS Trust
Covid19, Diabetes Mellitus, Type 2
Blood Sample Measurements and Physical Activity Levels in Type II Diabetes and/or COVID-19
It is known that COVID-19 has a more negative clinical course and causes higher degrees of morbidity and mortality in case of COVID-19 in diabetic patients.
- Trial name
- NCT04695158
- Testing
- COVID-19 group (Group I), Type II Diabetes Mellitus and COVID-19 group (Group II)
- Where
- Turkey (Türkiye)
- Volunteers
- 60 people, healthy volunteers welcome
- Sponsor
- Izmir Bakircay University
COVID-19
Keto-diet for Intubated Critical Care COVID-19
Coronavirus disease (COVID-2019) is a devastating viral illness that originated in Wuhan China in late 2019 and there are nearly 2 million confirmed cases.
- Trial name
- KICC-COVID19 (NCT04358835)
- Testing
- Ketogenic diet, standard of care
- Sponsor
- Johns Hopkins University
COVID-19
Impact of the Genetic Polymorphism on COVID-19 in Egypt
The COVID-19 infection severity depends on many factors, including genetic factors. The SNPs of ACE1, ACE2 and TMPRSS2; which have a big role in the viral entry to the cells, will be tested and help establish a relationship…
- Trial name
- NCT05157217
- Where
- Egypt
- Volunteers
- 98 people
- Sponsor
- Cairo University
Emergency Medicine, Cardiopulmonary Arrest
Intravascular Access in Suspected/Confirmed COVID-19 Patient
The current COVID-19 pandemic, this is especially since the transmission of SARS-CoV-2 is thought to occur mainly through respiratory droplets generated by coughing and sneezing, by direct contact with contaminated surfaces and…
- Conditions
- Emergency Medicine, Cardiopulmonary Arrest, Shock
- Trial name
- NCT04366947
- Testing
- NIO® (Intraosseous access), Standard of Care (Intravenous access)
- Where
- Poland
- Volunteers
- 60 people
- Sponsor
- Lazarski University
Arrhythmia, SARS-CoV-2 Infection
Study of Arrhythmia and ECG Abnormalities in Patients With COVID-19
Cardiac involvement has been described in Severe Acute Respiratory Syndrome - Coronavirus-2 (SARS-CoV-2) infection. Although there are no approved drugs to prevent or treat SARS-CoV-2 infection at present time, several…
- Trial name
- RYTHMO-COV (NCT04937621)
- Testing
- ECG data analysis, Treatment data collect, Biological check-up data collect
- Where
- France
- Volunteers
- 196 people
- Sponsor
- University Hospital, Bordeaux
Myocardial Infarction, Heart Diseases
Heart Patch for Myocardial Infarction COVID-19
Myocardial infarction (MI), as one of the many complications of COVID-19, is one of the contributing patients of patients' death.
- Trial name
- NCT04728906
- Testing
- Heart patch seeded with autologous cardiomyocytes and amnion epithelial stem cells
- Where
- 3 sites in Indonesia
- Volunteers
- 10 people
- Sponsor
- Rumah Sakit Pusat Angkatan Darat Gatot Soebroto
Chronic Hemodialysis Patients, Caregivers of Chronic Hemodialysis Patients
SeroCOVIDial Study: Assessment of COVID-19 Seroconversion in Patients on Chronic Hemodialysis and in Their Caregivers, a Cohort Study
Background: The preventive containment measures implemented in the COVID-19 pandemic are not feasible in chronic hemodialysis patients (HD) who need to attend their dialysis sessions 3 times a week.
- Trial name
- SeroCOVIDial (NCT04420338)
- Testing
- Blood sample, Serum tube collection
- Where
- France
- Volunteers
- 800 people
- Sponsor
- Assistance Publique Hopitaux De Marseille
Conscious Sedation, Pathologic Processes
Prospective Electroencephalography Evaluation of Sedation in COVID-19
Sedation of severe COVID-19 disease are often complicated. We try to find a correlate for this observation by encephalographic studies.
- Conditions
- Conscious Sedation, Pathologic Processes, Electroencephalogram, Acute Respiratory Distress Syndrome
- Trial name
- NCT04815109
- Testing
- Encephalography measurement
- Where
- Germany
- Volunteers
- 50 people
- Sponsor
- Goethe University
COVID-19, Quality of Life
Cohort Study for the Assessment of Long-term Impact of COVID-19 Among Mild COVID-19 Patients in Brazil
The present prospective cohort study aims to assess factors associated with of one-year health-related quality of life and physical, cognitive and mental health outcomes among adult patients with mild COVID-19.
- Conditions
- COVID-19, Quality of Life, Disability Physical, Disabilities Mental
- Trial name
- NCT05197647
- Testing
- Patients with symptomatic COVID-19 disease not requiring hospitalization.
- Where
- 14 sites in Brazil
- Volunteers
- 1,085 people
- Sponsor
- Hospital Moinhos de Vento
COVID-19
SHEN211 Tablets for the Treatment of Mild and Moderate Novel Corona Virus Infections (COVID-19)
Randomized, double-blind, placebo-controlled, multicenter phase II clinical study of SHEN211 tablets
- Trial name
- NCT06288893
- Testing
- SHEN211 Tablets
- Where
- China
- Volunteers
- 30 people
- Sponsor
- JKT Biopharma Co., Ltd.
ARDS, Human, COVID-19
London's Exogenous Surfactant Study for COVID19
The research team is investigating administering exogenous surfactant in COVID-19 patients with ARDS. The overall goal is to improve the outcome (mortality) of mechanically ventilated COVID-19 patients.
- Trial name
- LESSCOVID (NCT04375735)
- Testing
- Bovine Lipid Extract Surfactant
- Where
- 2 sites in Canada
- Volunteers
- 20 people
- Sponsor
- London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's
The first 1,020 results can be paged through. Add a filter or change the sort order to reach the rest.